GSK251
CAS No. 2125968-05-8
GSK251 ( —— )
Catalog No. M28226 CAS No. 2125968-05-8
GSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 626 | Get Quote |
|
10MG | 889 | Get Quote |
|
25MG | 1323 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2403 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK251
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
-
DescriptionGSK251 is a highly potent, highly selective, orally bioavailable inhibitor of PI3Kδ with a novel binding mode.
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2125968-05-8
-
Formula Weight584.7
-
Molecular FormulaC29H37FN6O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shan X, et al. Analytical techniques for monitoring of toluene and xylene exposure biomarkers hippuric acid and methylhippuric acid in human urine samples. Bioanalysis. 2021 Oct;13(20):1569-1584.
molnova catalog
related products
-
Acalisib
Acalisib (GS-9820, CAL-120) is a potent, isoform-selective PI3K p110δ with IC50 of 12.7 nM.
-
Parsaclisib HCl
Parsaclisib HCl is a selectve PI3Kδ inhibitor with antitumor activity. Parsaclisib demonstrates potent activity with IC50 values ranging from 0.2 to 2 nM.
-
ON 146040
ON 146040 is an effective inhibitor of PI3K isoforms with IC50s of 14 and 20 nM for PI3Kα and PI3Kδ, respectively.